Stock Comparison

NBIX vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricNBIXNeurocrine Biosciences, Inc.AAPLApple Inc.
Market Cap$13.3B$3.8T
Current Price$133.35$258.21
P/E Ratio40.5334.61
Revenue Growth 1Y24.8%6.4%
Net Margin14.5%26.9%
ROE14.2%171.4%
ROIC16.4%70.6%
Debt/Equity0.181.34
FCF Yield4.2%2.6%
Dividend Yield0.4%
Loading chart...

NBIX vs AAPL: Key Questions Answered

Which is the cheapest stock: NBIX or AAPL?

Based on P/E ratio, Apple Inc. (AAPL) is the cheapest at 34.6x earnings. Neurocrine Biosciences, Inc. (NBIX) is the most expensive at 40.5x. A lower P/E can indicate better value, but always consider growth rates too.

Which stock is growing the fastest: NBIX or AAPL?

Neurocrine Biosciences, Inc. (NBIX) is growing the fastest with 24.8% revenue growth. Apple Inc. has the slowest growth at 6.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: NBIX or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Neurocrine Biosciences, Inc. has the lowest at 14.5%. Higher margins indicate pricing power and efficiency.

Which is the largest company: NBIX or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. Neurocrine Biosciences, Inc. is the smallest at $13.3B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: NBIX or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Neurocrine Biosciences, Inc. has the lowest at 14.2%. Higher ROE indicates efficient use of capital.